Incubators for innovators

Lynn Kirkpatrick¹

¹PHusis Therapeutics, San Diego, California, USA.

Nature Biotechnology

|February 7, 2015

Summary

No abstract available in PubMed .

Related Concept Videos

You might also read

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pleckstrin Homology [PH] domain, structure, mechanism, and contribution to human disease.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2023

Same author

PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancer.

Experimental cell research·2021

Same author

Correction: An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors.

Cancer research·2019

Same author

An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors.

Cancer research·2019

Same author

A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy.

Investigational new drugs·2011

Same author

Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2010

Same journal

Author Correction: Sustained nitric oxide production by engineered E. coli remodels the tumor microenvironment and potentiates immunotherapy.

Nature biotechnology·2026

Same journal

Quantum computing in transition.

Nature biotechnology·2026

Same journal

Author Correction: Improved RNA base editing with guide RNAs mimicking highly edited endogenous ADAR substrates.

Nature biotechnology·2026

Same journal

Unlocking the chemical potential of filamentous fungi using prime editing.

Nature biotechnology·2026

Same journal

A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells.

Nature biotechnology·2026

Same journal

Prime editing for precise genome engineering and modulation of fungal metabolism.

Nature biotechnology·2026

See all related articles

Related Experiment Videos

Incubators for innovators

Related Concept Videos

Pleckstrin Homology [PH] domain, structure, mechanism, and contribution to human disease.

PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancer.

Correction: An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors.

An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors.

A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy.

Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice.

Author Correction: Sustained nitric oxide production by engineered E. coli remodels the tumor microenvironment and potentiates immunotherapy.

Quantum computing in transition.

Author Correction: Improved RNA base editing with guide RNAs mimicking highly edited endogenous ADAR substrates.

Unlocking the chemical potential of filamentous fungi using prime editing.

A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells.

Prime editing for precise genome engineering and modulation of fungal metabolism.

Related Experiment Videos

Incubators for innovators

Related Concept Videos

Pleckstrin Homology [PH] domain, structure, mechanism, and contribution to human disease.

PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancer.

Correction: An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors.

An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors.

A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy.

Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice.

Author Correction: Sustained nitric oxide production by engineered E. coli remodels the tumor microenvironment and potentiates immunotherapy.

Quantum computing in transition.

Author Correction: Improved RNA base editing with guide RNAs mimicking highly edited endogenous ADAR substrates.

Unlocking the chemical potential of filamentous fungi using prime editing.

A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells.

Prime editing for precise genome engineering and modulation of fungal metabolism.

Related Experiment Videos

Incubators for innovators

Related Concept Videos

Related Articles

Pleckstrin Homology [PH] domain, structure, mechanism, and contribution to human disease.

PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancer.

Correction: An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors.

An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors.

A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy.

Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice.

Author Correction: Sustained nitric oxide production by engineered E. coli remodels the tumor microenvironment and potentiates immunotherapy.

Quantum computing in transition.

Author Correction: Improved RNA base editing with guide RNAs mimicking highly edited endogenous ADAR substrates.

Unlocking the chemical potential of filamentous fungi using prime editing.

A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells.

Prime editing for precise genome engineering and modulation of fungal metabolism.

Related Experiment Videos

Incubators for innovators

Related Concept Videos

Related Articles

Pleckstrin Homology [PH] domain, structure, mechanism, and contribution to human disease.

PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancer.

Correction: An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors.

An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors.

A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy.

Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice.

Author Correction: Sustained nitric oxide production by engineered E. coli remodels the tumor microenvironment and potentiates immunotherapy.

Quantum computing in transition.

Author Correction: Improved RNA base editing with guide RNAs mimicking highly edited endogenous ADAR substrates.

Unlocking the chemical potential of filamentous fungi using prime editing.

A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells.

Prime editing for precise genome engineering and modulation of fungal metabolism.